Microtissues®

Summary

Published in Biotechnology Journal (2018), this peer-reviewed study used 3D Petri Dish® micro-molds to form scaffold-free 3D microtissues. Full citation: Nunes, Ana S., et al. Establishment of 2D Cell Cultures Derived From 3D MCF‐7 Spheroids Displaying a Doxorubicin Resistant Profile

🦠 Cell Biology

Establishment of 2D Cell Cultures Derived From 3D MCF‐7 Spheroids Displaying a Doxorubicin Resistant Profile

Biotechnology Journal 2018 Nunes, Ana S., et al
Cite as: Nunes, Ana S., et al. Establishment of 2D Cell Cultures Derived From 3D MCF‐7 Spheroids Displaying a Doxorubicin Resistant Profile. Biotechnology Journal (2018). doi:10.1002/biot.201800268 doi.org/10.1002/biot.201800268

Research Overview

3D cancer spheroids reproduce the drug resistance of solid tumors, which makes them attractive for screening — but most drug-discovery equipment and methods are standardized for 2D. This study tried to get both: take cells out of the 3D environment and keep the resistant phenotype in 2D culture.

MCF-7 breast cancer cells derived from 3D spheroids were subsequently cultured in 2D with medium supplemented with glutathione — an antioxidant found at high levels in breast cancer tissue and a known promoter of resistance — and their doxorubicin response was evaluated, testing whether a resistant 2D model can stand in for 3D during high-throughput screening.

Key Discoveries

  • 3D-derived MCF-7 cells re-cultured in 2D with glutathione supplementation
  • Doxorubicin response evaluated to test retention of the resistant phenotype
  • Aims to combine 3D-like drug resistance with standard 2D screening workflows